Monday, April 30, 2012

ChemoCentryx adds Pfizer's Feczko to board

ChemoCentryx Inc. said Monday it has added retired Pfizer Inc. executive Joseph Feczko to its board of directors, effective immediately. The Mountain View-based clinical-stage biopharmaceutical company (NASDAQ:CCXI) said Feczko was the senior vice president and chief medical officer of Pfizer and member of its executive leadership team with global responsibilities for all aspects of the company's medical, regulatory and safety activities. He retired in May 2009.

No comments:

Post a Comment